Treatment, Medication & Supplement Directory
A comprehensive encyclopedia of medicines, chemotherapy protocols, targeted and immune therapies, supplements, Chinese herbal formulas, Traditional Chinese Veterinary Medicine (TCVM) approaches, and supportive-care options used or discussed in canine and feline tumor care. Directory entries explain what each option is, where it may fit, its evidence and safety boundaries, and what to discuss with a veterinarian; they are references, not individualized prescriptions or rankings.
Named profile STUBBS S-Onco: Product ProfileRepresentative category illustration – no product packaging is shown.STUBBS S-Onco: Product Profile
STUBBS S-Onco is a named branded product for Dogs and cats of all breeds and ages according to the manufacturer; manufacturer positioning must be kept separate from independent…
Read more
Named profile Prednisolone in Feline and Canine Oncology: Uses and Safety BoundariesRepresentative category illustration – no product packaging is shown.Prednisolone in Feline and Canine Oncology: Uses and Safety Boundaries
prednisolone is covered as glucocorticoid with lympholytic, anti-inflammatory and supportive-care roles, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read moreNamed profile Piroxicam in Veterinary Oncology: NSAID Evidence and Interaction SafetyRepresentative category illustration – no product packaging is shown.Piroxicam in Veterinary Oncology: NSAID Evidence and Interaction Safety
piroxicam is covered as nonsteroidal anti-inflammatory drug used extra-label in selected veterinary oncology contexts, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read more
Named profile Ifosfamide in Veterinary Oncology: Uroprotection and Organ-Safety ProfileRepresentative category illustration – no product packaging is shown.Ifosfamide in Veterinary Oncology: Uroprotection and Organ-Safety Profile
ifosfamide is covered as oxazaphosphorine alkylating agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read moreNamed profile Streptozotocin for Canine Insulinoma: Narrow-Indication Chemotherapy ProfileRepresentative category illustration – no product packaging is shown.Streptozotocin for Canine Insulinoma: Narrow-Indication Chemotherapy Profile
streptozotocin is covered as nitrosourea antineoplastic agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read moreNamed profile Dacarbazine in Veterinary Oncology: Infusion and Gastrointestinal-Risk ProfileRepresentative category illustration – no product packaging is shown.Dacarbazine in Veterinary Oncology: Infusion and Gastrointestinal-Risk Profile
dacarbazine is covered as triazene antineoplastic agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read more
Named profile Temozolomide in Veterinary Oncology: Oral Alkylator and Evidence BoundaryRepresentative category illustration – no product packaging is shown.Temozolomide in Veterinary Oncology: Oral Alkylator and Evidence Boundary
temozolomide is covered as triazene antineoplastic agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read moreNamed profile 5-Fluorouracil in Veterinary Oncology: Critical Feline Toxicity WarningRepresentative category illustration – no product packaging is shown.5-Fluorouracil in Veterinary Oncology: Critical Feline Toxicity Warning
5-fluorouracil (5-FU) is covered as fluoropyrimidine antimetabolites; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read moreNamed profile Bleomycin in Veterinary Oncology: Local, Intracavitary and Pulmonary-Risk ProfileRepresentative category illustration – no product packaging is shown.Bleomycin in Veterinary Oncology: Local, Intracavitary and Pulmonary-Risk Profile
bleomycin is covered as antineoplastic glycopeptide antibiotics; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read moreNamed profile Vinorelbine in Veterinary Oncology: Lung-Tumour and Marrow-Safety ProfileRepresentative category illustration – no product packaging is shown.Vinorelbine in Veterinary Oncology: Lung-Tumour and Marrow-Safety Profile
vinorelbine is covered as vinca alkaloid antimitotics; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read moreNamed profile Mitotane in Canine Adrenal Disease and Adrenocortical TumoursRepresentative category illustration – no product packaging is shown.Mitotane in Canine Adrenal Disease and Adrenocortical Tumours
mitotane (o,p′-DDD) is covered as adrenocorticolytic agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read moreNamed profile Hydroxyurea in Veterinary Oncology: Myeloproliferative-Disease ProfileRepresentative category illustration – no product packaging is shown.Hydroxyurea in Veterinary Oncology: Myeloproliferative-Disease Profile
hydroxyurea is covered as ribonucleotide-reductase inhibitors; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read more